Evidence map›Paper›PMID 41055075›Full record

ArticleJournal of the International AIDS Society2025

Prevalence and risk factors of hypertension and diabetes among persons living with HIV in Zambia: results of a national facility-based cross-sectional survey.

Chomba Mandyata, Sivile Suilanji, Samuel Bosomprah, Paul Somwe, Cosmas Zyambo, Mwiche Musukuma, Aggrey Mweemba, Malizgani Paul Chavula, Chipefwe Sichilima, Phoebe Bwembya and 6 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chomba MandyataSchool of Public Health, University of Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-0990-1599
Sivile SuilanjiMinistry of Health, Lusaka, Zambia.
Samuel BosomprahCenter for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Paul SomweCenter for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Cosmas ZyamboSchool of Public Health, University of Zambia, Lusaka, Zambia.
Mwiche MusukumaSchool of Public Health, University of Zambia, Lusaka, Zambia.
Aggrey MweembaMinistry of Health, Lusaka, Zambia.
Malizgani Paul ChavulaSchool of Public Health, University of Zambia, Lusaka, Zambia.
Chipefwe SichilimaSchool of Public Health, University of Zambia, Lusaka, Zambia.
Phoebe BwembyaSchool of Public Health, University of Zambia, Lusaka, Zambia.
Mpanji SiwingwaMinistry of Health, Lusaka, Zambia.
Richard ChibaleMinistry of Health, Lusaka, Zambia.
Henry PhiriMinistry of Health, Lusaka, Zambia.
Joseph ZuluSchool of Public Health, University of Zambia, Lusaka, Zambia.
Halwindi HikabasaSchool of Public Health, University of Zambia, Lusaka, Zambia.
Wilbroad MutaleSchool of Public Health, University of Zambia, Lusaka, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite growing evidence on the rising burden of non-communicable diseases (NCDs) in sub-Saharan Africa, the national prevalence of hypertension, prediabetes and diabetes among persons living with HIV (PLHIV) in Zambia is largely unknown. This study aimed to determine the national prevalence of hypertension and diabetes mellitus and their associated risk factors among adult PLHIV in Zambia.

methodsWe conducted a cross-sectional study in 149 antiretroviral therapy (ART) clinics located in 52 rural and urban districts in Zambia based on the adapted World Health Organization (WHO) STEPwise approach to NCD risk factor Surveillance (STEPS) and the Zambia Population-Based HIV Impact Assessment (ZAMPHIA) questionnaire. We used proportional to size sampling to select districts and clinics, targeting 5775 PLHIV. Data was collected from 1 October 2023 to 30 November 2023. We estimated the prevalence of hypertension and diabetes mellitus and used robust Poisson regression to analyse associations with socio-demographic, behavioural and HIV-related risk factors, and reported prevalence ratios (PR).

resultsIn the final analysis, we included a total of 5204 participants from 52 districts and 149 ART clinics countrywide: 67.2% were female, and 71.3% were from urban areas. The prevalence of hypertension, prediabetes and diabetes was 22.5% (95% confidence interval [CI]: 21.3-23.6), 26.7% (CI: 25.5-27.9) and 12.5% (CI: 11.6-13.4), respectively. In the multivariable model, being 30-44 (PR = 2.1; CI: 1.5-2.9), 45-49 (PR = 3.3; CI: 2.4-4.7) and 60 years or older (PR = 4.7; CI: 3.3-6.8) compared to those aged 18-29; widowed, divorced or separated individuals compared to those never married; being overweight (PR = 1.4; CI: 1.2-1.5) and obese (PR = 1.9; CI: 1.6-2.1) compared to normal weight PLHIV was associated with hypertension. College or university-educated PLHIV (PR = 2.1; CI: 1.3-3.4), compared to those with no formal education; and those with high total cholesterol ≥6.2 mmol/l (PR = 2.2; CI: 1.4-3.6), versus desirable total cholesterol (<5.2 mmol/l); being overweight (PR = 1.4; CI: 1.1-1.6) and obese (PR = 1.6; CI: 1.3-2.0), compared to those with normal weight, showed a significant association with diabetes mellitus.

conclusionsThe prevalence of hypertension and diabetes mellitus among PLHIV in Zambia was notably high. This underscores the need for immediate and robust intervention strategies to mitigate the high prevalence of hypertension and diabetes mellitus, along with their associated risk factors, particularly within this vulnerable demographic.

Indexed as

Diabetes MellitusHIV InfectionsHypertensionAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsSurveys and QuestionnairesYoung AdultZambiablood pressurediabetes mellitusglycosylated A1cHIVhypertensionnon‐communicable diseasesprediabetes

Identifiers

PMID41055075
PMCPMC12501770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.